Top
Bluestem
  • Who We Are
  • Strategy
  • Portfolio
  • Newsroom
  • INVESTOR PORTAL 2025
Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/
iStock-645678506 dark.png
Bluestem

Newsroom

Bluestem
  • Who We Are/
  • Strategy/
  • Portfolio/
  • Newsroom/
  • INVESTOR PORTAL 2025/

News From the Bluestem Team


December 10, 2025

SYD-101 in the News

December 10, 2025/ Michele Kleinwolterink

From Eye Care Insiders, this video features Dr. Allen who highlights the latest in the field of myopia management, including FDA approval for Stellest lens and a complete response letter for SYD-101. Click here to view the video.

Shared by Tyler Stowater, board member of Sydnexis, Inc.

December 10, 2025/ Michele Kleinwolterink/

Michele Kleinwolterink

  • Newsroom
  • Santen Receives UK Approval for ...

*Legal Disclaimer: NEWSROOM The content provided herein is for informational and convenience purposes only. The information provided on this website does not constitute an offer to buy or sell any securities or provide any form of investment advice.  Bluestem Capital Company, LLC assumes no responsibility nor makes any claims as to the quality, accuracy or usefulness of third-party linked content made available on this site.

Bluestem is the registered service mark of Bluestem Capital Company, LLC. All Rights Reserved.